Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Proteomics. Clinical Applications|March 31, 2015
Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophreniaJulian A Jaros, Hassan Rahmoune, Hendrik Wesseling, et al.
CNS Drugs|July 20, 2018
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological InterventionF Markus Leweke, Juliane K Mueller, Bettina Lange, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2004
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptomsAndrea Giuffrida, F Markus Leweke, Christoph W Gerth, et al.
Frontiers in Psychiatry|April 1, 2022
Editorial: Immune Associated Mental Illnesses in Adolescents and Young Adults: Pathophysiological Role and Therapeutic PerspectivesRichard B Banati, Cathrin Rohleder, F Markus Leweke, et al.
Translational Psychiatry|May 28, 2026
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disordersTimothy A Couttas, Anna E Hoffmann, Beverly Jieu, et al.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
Alterations of primary fatty acid amides in serum of patients with severe mental illnessEmanuel Schwarz, Phil Whitfield, Sven Nahnsen, et al.
Journal of Neurology|June 18, 2010
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosisHela-Felicitas Petereit, Dirk Reske, Hayrettin Tumani, et al.
Frontiers in Behavioral Neuroscience|June 7, 2014
Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake ratsCathrin Rohleder, Fabienne Jung, Hanna Mertgens, et al.
Neuroscience Letters|December 31, 2013
Hypocretin in cerebrospinal fluid is positively correlated with Tau and pTauMichael Deuschle, Claudia Schilling, F Markus Leweke, et al.
Schizophrenia Research|November 28, 2016
Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical featuresJennifer M Coughlin, Lindsay N Hayes, Teppei Tanaka, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Proteomics. Clinical Applications|March 31, 2015
Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophreniaJulian A Jaros, Hassan Rahmoune, Hendrik Wesseling, et al.
CNS Drugs|July 20, 2018
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological InterventionF Markus Leweke, Juliane K Mueller, Bettina Lange, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2004
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptomsAndrea Giuffrida, F Markus Leweke, Christoph W Gerth, et al.
Frontiers in Psychiatry|April 1, 2022
Editorial: Immune Associated Mental Illnesses in Adolescents and Young Adults: Pathophysiological Role and Therapeutic PerspectivesRichard B Banati, Cathrin Rohleder, F Markus Leweke, et al.
Translational Psychiatry|May 28, 2026
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disordersTimothy A Couttas, Anna E Hoffmann, Beverly Jieu, et al.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
Alterations of primary fatty acid amides in serum of patients with severe mental illnessEmanuel Schwarz, Phil Whitfield, Sven Nahnsen, et al.
Journal of Neurology|June 18, 2010
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosisHela-Felicitas Petereit, Dirk Reske, Hayrettin Tumani, et al.
Frontiers in Behavioral Neuroscience|June 7, 2014
Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake ratsCathrin Rohleder, Fabienne Jung, Hanna Mertgens, et al.
Neuroscience Letters|December 31, 2013
Hypocretin in cerebrospinal fluid is positively correlated with Tau and pTauMichael Deuschle, Claudia Schilling, F Markus Leweke, et al.
Schizophrenia Research|November 28, 2016
Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical featuresJennifer M Coughlin, Lindsay N Hayes, Teppei Tanaka, et al.
Pageof 12